In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus
about
Carbapenems: past, present, and futureIn vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infectionsThe Role of msa in Staphylococcus aureus Biofilm Formation.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the EuIn vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptidesAntimicrobial, antioxidant, and antitumor activity of epsilon-poly-L-lysine and citral, alone or in combination.Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.Effect of nisin and perilla oil combination against Listeria monocytogenes and Staphylococcus aureus in milkAdvances in MRSA drug discovery: where are we and where do we need to be?In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance.In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus.In vitro activity of linezolid alone and combined with other antibiotics against clinical enterococcal isolates.Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteriaSuppressive drug combinations and their potential to combat antibiotic resistance.In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA).Antimicrobial synergism and cytotoxic properties of Citrus limon L., Piper nigrum L. and Melaleuca alternifolia (Maiden and Betche) Cheel essential oils.Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).Prevalence and associated factors of metabolic syndrome among South Korean adults.Antibacterial combination therapy using Co3+, Cu2+, Zn2+ and Pd2+ complexes: Their calf thymus DNA binding studies.Synergistic activity of 1-(1-naphthylmethyl)-piperazine with ciprofloxacin against clinically resistant Staphylococcus aureus, as determined by different methods
P2860
Q24634999-96DB392C-DEBB-47FC-8CC3-3BDE9EAB5623Q33299938-4491EE05-FF90-448D-96B6-685CAB467871Q33393422-D01D09C8-5A01-484C-93A2-D8B0D93CDDC2Q34611253-905EAB71-A6BF-4EC9-961E-D62A3FDA95B0Q35083990-F2A82D66-238F-43FD-9E74-3A18A6BF2B15Q36055012-737C3FA8-FE47-4C7C-A3C7-5B696EB18395Q36283731-386F8456-AF4B-41A6-8802-FCEE5B767D4CQ37110079-04D849EA-B893-4515-8B66-B19B664D8F9DQ37112508-D5396855-4336-43DD-ADCC-CFD0867BF086Q41377043-05CC0493-0377-4613-8A46-4BB63FE7A753Q41474175-17E9A4B8-0C88-4B61-9690-0CD68944CF07Q41512841-A34486B4-001A-4E65-B732-F68210313786Q41996646-5558DA47-9E76-4105-90C2-720BA180C817Q42001450-06D2AAA9-E211-4C0C-9847-788047B1B205Q42027484-45EA556D-D5FB-43DB-B0BA-055D156BFB11Q42374803-B00301EE-A6A1-45FE-AD57-530F67031D95Q42612662-58A1635E-5667-48A5-9C9E-4AFE84AFADAEQ42627381-8EF0155B-179F-4FBC-B58D-07E4F5DD88B3Q43636170-6A8105C3-992A-4CE2-BF59-339366E96066Q48226991-8C1F9284-5263-47FA-B67D-C639280B7AE6Q51063904-C2EA39B8-9D4F-4BEC-8246-F4B167DCC86CQ51307995-9C9D3331-D123-41B6-883F-02B36DEE3F9BQ52753218-AB04FF82-6299-4181-ADC0-93FFDFC73553Q56770342-C239F9B1-CC3A-407A-BEEE-738E4D35C445
P2860
In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@ast
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@en
In vitro and in vivo synergist ...... sistant Staphylococcus aureus.
@nl
type
label
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@ast
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@en
In vitro and in vivo synergist ...... sistant Staphylococcus aureus.
@nl
prefLabel
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@ast
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@en
In vitro and in vivo synergist ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P1476
In vitro and in vivo synergist ...... esistant Staphylococcus aureus
@en
P2093
Anne-Françoise Miegeville
Denis Bugnon
Dominique Navas
Gilles Potel
Jocelyne Caillon
Marie-France Kergueris
Virginie Le Mabecque
P2860
P356
10.1128/AAC.49.1.45-51.2005
P407
P577
2005-01-01T00:00:00Z